Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target

MLA

Seo-Young Park, et al. “Establishment of Canine Mammary Gland Tumor Cell Lines Harboring PI3K/Akt Activation as a Therapeutic Target.” BMC Veterinary Research, vol. 20, no. 1, May 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12917-024-04085-w.

APA

Seo-Young Park, Yeong-Bin Baek, Chan-Ho Lee, Hyun-Jin Kim, Hwang-Phill Kim, Young-Jun Jeon, Jung Eun Song, Su-Bin Jung, Hyo-Jin Kim, Kyeong-Seo Moon, Sang-Ik Park, Chang-Min Lee, & Sung-Hak Kim. (2024). Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target. BMC Veterinary Research, 20(1), 1–13. https://doi.org/10.1186/s12917-024-04085-w

Chicago

Seo-Young Park, Yeong-Bin Baek, Chan-Ho Lee, Hyun-Jin Kim, Hwang-Phill Kim, Young-Jun Jeon, Jung Eun Song, et al. 2024. “Establishment of Canine Mammary Gland Tumor Cell Lines Harboring PI3K/Akt Activation as a Therapeutic Target.” BMC Veterinary Research 20 (1): 1–13. doi:10.1186/s12917-024-04085-w.